Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

182 - Psychedelics & Recreational Drugs

Read full show notes here: https://bit.ly/3EwSJ2y David Nutt is a psychiatrist, neuroscientist, and the Director of the Neuropsychopharmacology Unit in the Division of Brain Sciences at the Imperial College London. His research focuses on illicit drugs—their harm, classification, and potential for therapeutic use in psychiatry. In this episode, David discusses his framework for assessing the potential harm caused by common recreational drugs and explains how they are regulated, which is oftentimes misaligned with actual risk. He describes in detail the neurobiology, mechanisms of action, and addiction potential of alcohol, opiates, cocaine, and methamphetamine and contrasts those with psychedelics, which have been given a similar regulatory classification despite their relatively low risk of harm and their numerous potential therapeutic uses. Additionally, David explains the promise of psychedelics like ketamine, MDMA, and psilocybin for treating drug addiction and depression and discusses how political pressures have created roadblocks to future necessary research. We discuss: 00:00:00 - intro 00:00:10 - David’s early interest in the brain and experience in psychiatry 00:08:00 - David’s brief work on government drug policy in the UK 00:11:20 - A scale for rating the relative harm of certain drugs 00:17:44 - The contrast in regulation between cannabis vs. alcohol and why research on potential benefits of cannabis is lacking 00:23:35 - The opiate crisis and rise of fentanyl: the cause and potential solution 00:33:11 - The science of addiction and the potential use of psychedelics for treating drug addiction 00:41:32 - Cocaine: mechanisms of action and risks 00:48:38 - Methamphetamine and crystal meth: mechanisms of action and neurotoxicity 00:53:12 - How psychedelics came to be classified as schedule I drugs despite their numerous therapeutic uses 01:09:45 - The history of MDMA and the bad science and political forces leading to its demonization 01:14:26 - History of ketamine, medical use of esketamine, and the waning effects of psychedelics with increasing usage 01:21:28 - Psilocybin for depression: David’s promising research and the roadblocks to more robust experiments -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 35 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more about Peter: https://bit.ly/313cDn5 Subscribe to receive exclusive subscriber-only content: https://bit.ly/3Bw5wjA Sign up to receive Peter's email newsletter: https://bit.ly/3mqxDMM Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostDavid Nuttguest
Nov 1, 20211h 40mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

David Nutt Challenges Drug Harm Rankings, Scheduling, and Psychedelic Medicine Prohibition

  1. David Nutt explains that his multi-criteria analysis, using 16 harm scales, ranks alcohol as the most harmful drug overall while magic mushrooms, LSD and MDMA rank among the least harmful.
  2. Nutt describes the fentanyl crisis as a chain of mistakes: heavy opioid prescribing, a crackdown that pushed dependent users to the black market, and cartels shifting to far more potent fentanyls.
  3. Nutt argues that LSD, psilocybin and MDMA were banned for political and social reasons rather than evidence of harm, halting promising research on alcoholism and depression.
  4. The conversation covers how cocaine, methamphetamine and ketamine act on the brain and where their risks lie, including cardiac effects, dopamine disruption, and bladder and cognitive damage from heavy ketamine use.
  5. Nutt reports that his psilocybin versus escitalopram study showed no difference on the primary measure but favored psilocybin on other measures such as sexual dysfunction and wellbeing, and he says Schedule I status blocks follow-up work such as microdosing studies.

IDEAS WORTH REMEMBERING

5 ideas

Legal status does not track measured harm

Nutt says his harm analysis found the most vilified drugs to be the least dangerous, with alcohol topping the overall ranking because of its wide use and harm to others, while alcohol ranks only about fourth for harm to the user.

The fentanyl crisis resulted from a cascade of policy failures

Nutt says overprescribing, an abrupt crackdown without alternatives, and limits on poppy cultivation led users to the black market and cartels toward fentanyl, which he says is 50 times more potent than heroin and cheaper to make.

Prohibition has blocked research on potential benefits

Nutt notes that federal illegality kept NIDA from funding cannabis benefit research even after California legalized medical cannabis, and Schedule I rules make microdosing trials unaffordable.

Psychedelics may work by disrupting the default mode network

Nutt says the default mode network holds the sense of self, and that disrupting overly rigid patterns there could loosen depressive thinking or compulsive drug seeking.

LSD research was productive before it was banned

Nutt says about 40,000 patients and a thousand papers showed LSD was safe and effective, and a meta-analysis of alcoholism trials found an effect size of one, twice that of later treatments.

WORDS WORTH SAVING

5 quotes

The real paradox of doing this really in-depth multi-criteria decision analysis is it turns out that the drugs that have been most vilified and which we've been taught are the most dangerous turn out to be the least dangerous.

— David Nutt

So the equation is so balanced against the decision that was made. It really, I think it's the worst censorship of research in the history of the world.

— David Nutt

I realized that the drug policy wasn't in any way evidence-based, and when I tried to bring evidence to bear on drug policy, they sacked me because it's much more convenient to have a political decision-making about drugs than it is to have an evidence-based one.

— David Nutt

Whereas psilocybin is stopping the thinking and allowing the rest of your brain to work normally.

— David Nutt

Of course, all that happens is in the end, young people think this doesn't make sense, and then they discover they've been lied to. So are they gonna listen to anything else the government tells them?

— David Nutt

Multi-criteria drug harm assessmentAlcohol versus cannabis regulationOpioid and fentanyl crisisDefault mode network and addictionIbogaine for opioid dependenceHistory of LSD, MDMA and psilocybin schedulingPsilocybin versus Lexapro for depression

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.